BRIAN THOMPSON: Open Payments
NPI 1285234096 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 104 payments from 19 companies in 2025. Trend: 2023 $636 · 2024 $764 · 2025 $1,811
Food & beverage: $1,811
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $511 |
| Novo Nordisk Inc | 18 | $218 |
| PFIZER INC. | 12 | $203 |
| Amgen Inc. | 18 | $177 |
| ABBVIE INC. | 15 | $155 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| Lilly USA, LLC | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $61 |
| Axsome Therapeutics, Inc. | 3 | $59 |
Products named: BREZTRI, AIRSUPRA, ELIQUIS, OTEZLA, Ozempic, CAPLYTA, Wegovy, MOUNJARO.
Industry payments across IN — which companies pay providers there.
